https://www.reddit.com/r/pennystocks/comments/m3p9v5/dtgi_otcqb_institutional_investor_what_do_they_see/

Any insight here would be appreciated. Been following for a few months

Agreed. Looking at dollar volume its gotta be close

https://www.snagajob.com/search/w-rahway,+nj/q-dc+solar+integrators+llc

Also not sure if new to yall but dc solar job postings yday and today.

I mean you can call yourself. I talked to Jay if that helps. Its public info since the CEO tweeted it but they couldnt tell me anything more ???????

Just called M&K cpa’s their audit firm and talked with a partner and they say they are currently still auditing financials for SPSO - if thats new or not to anyone here. Also called the secuirites counsel yesterday and had him call the ceo and empty the investor voice mail so now you can leave voicemails when you call ha. At least we know ceo is alive if securities counsel got through to him. Going to get a hold of their TA and lawfirm next.

The added restricted shares have my interest. Picked up some just for that reason. Theyre super active on Facebook i just wish they would get fins done. Wonder if the restricted shares were payment to auditors

https://www.reddit.com/r/pennystocks/comments/lpno75/rxmd_progressive_care_otcqb_40_million_revenue/?utm_source=share&utm_medium=ios_app&utm_name=iossmf

Give the post some love!

Haven’t even posted dd on reddit yet, great movement today. Looking for 20-30 cents in a few weeks. Volume profile is clear above here and will have little resistance.

$RXMD
- 40.2 Million annual revenue, high growth.
- S-1 for uplist submitted for approval
- Undervalued, 40 m market cap, should be 4-5x this.
- Excellent leadership team, board member is also ceo of $NETE on nasdaq.
- Long term hold. Looking for dollars eventually. pic.twitter.com/8e4chyVSSu

— Archer (@Arch1inc) February 17, 2021

I’ve been alerting in a few places ha. I plan on doing a reddit write up soon for the company. Was an early investor in ALP* and saw the same revenue growth there as here. Seems very hidden. I like the S-1 timeline here as well

Hi all, I called the auditing firm and talked to the main auditor there and confirmed today that the S-1 was received by the SEC and they have already been sent a letter back requesting changes (all normal for S-1 filing process). They are working on auditing the annual report to update for the S-1 and after that will see if that is all that needs to be done. Then we wait for the Effect filing! I'd say we are pretty close. Usually annuals are due late march for OTC Filers

Thats odd. I’ll have to call them this week. They are usually pretty good at keeping tickers current, they represent a good section of F500 companies.

Thats me. Interested to see if anything turns up.

Lol. Company came out of grey market today. Wonder whats happening

Odd, wonder whats up here

So DTGI decided not to renew their contract with paypoint ir and instead contracted with eversull, some random ir team with a 1995 website. + I can’t get stephan to answer any questions about their twitter looking like a pump fest and the future in regards to inhouse ir. Hoping to see someone step up to the plate and communicate with shareholders soon. Sent an entire paragraph to Stephan for a 5 word answer??

Have a large position :) undervalued and positive 2021 will be a good year.

Google is a real thing, and this was answered before. However ill answer again. When a company (ALPP) acquires another company there are sometimes contingent considerations in the contract for acquisition. Pretty much at acquisition its an agreement to transfer assets to whoever is selling their share. Its a normal part of balance sheets for companies that acquire

Also O/S for ALPP on Dec 31st 2018 was 26,567,410 per 10-K filing, and the o/s at the end of 2019 was 99,710,000 million. Where are the extra 25 million shares of dilution coming from..considering of course ALPP’s AS was only 100 million in 2019....stop with the lying. Also if we are considering companies that dilute 100mm shares in a year, wow is there a list of companies making a vaccine right now that really are scams! PFE AZN INO NVAX...

In fact I point the opposite picture, Kent is a great CEO who instead of raising the AS to 1 billion and letting all the notes convert from the 2018 10-k filing, he paid them down, refinanced them all, and got it to a managable amount...I will glady take the 90% reduction in dilution!! That number was certainly scary to see in the 2018 annual but its eliminated now, amazing.

Thanks for the confirmation you do not know the answer to the question!

To answer the equity raise with LPC. Why are people so up in arms here? How else is ALPP suppose to quickly clean up the balance sheet to move on? Take out more notes? no...the next thing...equity raise... 90% of companies do equity raises for shares when they are gaining traction..its what they do. GNUS did over 30 million in equity raises for shares in 3 months, IBIO TOPS SHIP CTRM as well for recent ones. In fact LPC has deals with some other companies that are doing quite well, and they utilize it (like IBIO). But whats so wrong about selling shares for money exactly? Amazon did an 8 million series A capital raise when it began. Why can't ALPP? The difference here is, people choose to look at the dark. Oh LPC will sell their shares oh no! Well would someone rather want more notes with dilution and debt or a clean capital raise for shares. Choice is obvious, and as seen by almost every single company on the NYSE and NASDAQ its a great one. Lets also not forget that Every Single Company that ipo's or uplists has to have the backing of an institution and sells shares for capital and provides detail for the use of said capital...S-1's for every single company. Was ALPP suppose to not do a capital raise at uplist to fund operations once on a national exchange? Again I ask...whats the point of uplisting if it is not to get capital..why even go public? That is what public companies do.

All due respect. I would hope an answer to my previous reply to your other post. I also am going to answer the fair value of contingent on the balance sheet. This can be equity or liability, its money that will usually be paid in cash for acquisitions by the acquisition company. Which makes sense because ALPP is a holding company that does acquisitions.

Now talking about the r/s. Personally, the r/s to me feels good. Once on the nasdaq or nyse the stock will get institutional investors and analyst coverage. They will see the industry ALPP is in and the ultra undervalued stock compared to its peers which have a forward p/e ratio average of 22.8 according to TDA. Investors will see the debt to equity ratio changing and the assets begin to normalize the liabilities. In fact investors may even see the insane revenue growth while somehow decreasing the stockholder debt and liability difference each quarter! It's amazing what is happening here, and the speculation once on an upper exchange will push the stock forward. R/S are good when the stock has revenue and is real, most OTC traders are use to garbage r/m or stocks that have 800k in revenue or are dilution monsters. However, there is no more convertible debt for ALPP. There is hardly any room for dilution, and there won't be much (if any, there is 14 mil share left in the o/s). That is cake compared to all of these other OTC's. Again, as an options trader who trades on fundamentals and TA. Everything is there for a great company to succeed for many years down the line. Most don't want to accept it, but debt runs the world now. And it runs companies too! At last screening 15 companies in the S&P500 didn't have debt...what a surprise! Another bonus is ALPP's debt is now LONGTERM. AAPL MSFT TWTR SQ NVDA TSLA UBER BYND BA all have long term debt, it's how they continue to grow as companies. ALPP is doing the same and its doing a great job. With the short term debt out of the way for now I expect to see a great end of the year.

Not sure what you mean by high lol. But this is one of the only OTC’s I trade. I’m inherently an option trader and go based off of TA and fundametals. ALPP is just very appealing to me. In it’s industry its trading incredibly low, and some of the national exchange stocks that are similar are blown out of proportion. Just funny to see it here on the OTC low. I bet one day on NYSE NASDAQ it’ll be trading at a gigantic forward p/e like its peers.

Isn’t that why a company goes public though? To raise money through capital offers? Just like NKLA TSLA CTRM IBIO literally any stock from any sector does - offerings of shares for capital. Share holders are okay with this because it helps the company, in 2019 around 80 mil shares were diluted, Q1 10.6 mil. Q2 0 shares thus far. Comparatively to other ‘growing’ otc companies like TLSS BBRW OZSC OPTI and the list goes on...alpp has diluted practically nothing compared to the billions they have. I’m glad we have a CEO that knows how to refinance debt *cough* looking at TLSS’s billionaire ceo who let 300 mil dilution happen and then raised the a/s again, now 5x alpp’s. ALPP is doing a fine job - even with dilution it’s impossible to argue the company is not undervalued based on ev value alone no? And there has been no dilution since feb 1st, the last time a share diluted! Of course you could bash this stock for refinancing and diluting to its small o/s or go love the other companies with legitamately billions in dilution :)

You can either have a bankrupt otc ticker or dilution - that is how the otc works, they are unable to get normal capital raises from institutions so they have to take out notes. However ALPP hasn’t even taken out any notes since 2019, only notes are for acquisitions which are beneficial long run to the company. But if you look at big boards like most recently UBER or ERI how are they doing their acquisitions??? It IS up to the shareholders to pay, thats why companies go public.

In my honesy opinion the best strategy for ALPP is to consolidate cash for now and wait on acquisitions till Q4 at earliest, not only will a lot of companies be cheap because of the pandemic but they could probably acquire a sizable one with capital and help from their credit lender.

Question, but I was doing some indepth reviewing of the balance sheets and I noticed that since Q2 2019 it has only been getting better for ALPP?

In fact since Q2 2019 the deficit and debt to asset ratio has only shrunk. From Q2 2019 the deficit was -14 million, to currently -9 million. That’s huge for the span of 3 quarters... Also the companies assets have gone from 26.5 mil to 39 million (+12.5 mil) while liabilities have gone from 41 mil to 49 mil (+8 mil). This is huge, the closer ALPP gets to an even a/l ratio the better. In fact, most companies consider an equal ratio healthy standing. So has ALPP finally turned the situation around? Debt decreasing, debt ratio decreasing, asset growth overtaking liability growth, no more convertible liability, consistent revenues. Is the company not pulling through? What am I missing here, an explanation would be helpful. Thank you

Side note, calculated the EBITDA for Q1 and it was positive 2.2 million, compared to last quarter this is pretty big.

I think considering thats way wrong. XSPA just had a quarter with a 10 million net loss on 7.7 million revenue and somehow institution gobbled up shares during their offering. In fact 10% of XSPA is owned by institutions. ALPP’s balance sheet looks really good considering the world runs on debt. Compared to recent earnings from companies, it would even look exemplary! Take a look at the hot tickers recently and compare balance sheets, I see large net losses everywhere, yet we are complaining about ALPP being slightly positive. There needs to be a point made that debt is not terrible anymore, the United States runs on debt. Most big boards run on it. What should be looked at is potential, and ALPP has alot of potential in the future. Give it 2 years or so and ALPP will be riding just fine on NYSE/NASDAQ.

This is false. The debt was paid off. As per page 6, taking away the 2.3 million in derivative liability payments would leave the net cash per operating activities positive 2.49 million.

As per page 28, the convertible notes were repaid during the three months ended mar 31.

But the cash was used in good places.
1.) to eliminate the 2.3 million in FCN
2.) for the acquisition of excel in february (2 million)
That’s 4 million used in the benefit of the company, I do not see how just having this cash sitting around instead is any better. I would rather see it used for these kinds of operations, personally.

ALPP paid off 2.2 million in fixed notes, the ones from the november consolidation 8-k I believe. All in 3 months, derivative liability section. Thats huge. Also managed to pay down some other subsequent notes!

Ouch. Dilution share count from 10-Q is ar 1.5 billion. Definitely calculated with a smaller share price in mind. Sad to see they couldn’t get it under control through refinancing or other means.

Hello all! There is reasonable cause to believe dilution is finally over. The common dilution tickers PUAL and VERT both got off of the ask by 2 pm. No t-trade after hours for the first time in 5 trading days as well. O/s seems to be around 170 million right now. No email from transfer agent still, however.

Hey yall. Made a reddit post explaining the dilution for BBRW and where we are at. https://www.reddit.com/r/pennystocks/comments/hcbaxf/bbrw_how_to_play_stocks_with_dilution_and_how_to/
Dilution like this is not always bad. Once its out of the way hopefully no more notes will have to be taken out. Especially if we buy back the float we will be sitting pretty. Next week is shaping up for a great week!

Another t-trade. I expected 1 more for 5.5 million tomorrow, and that should be close to all of the notes converted per 10-k.

Has anyone ever gotten a response on email from BBRW? Seems my questions go unloomed

Hello! Been a while since I last was here but stopped in and saw the talks of dilution. Just email IR if you think there is dilution going on. Here is from today :. The o/s has not changed.

you can also check Ycharts which has the out standing share count staying the same since feb 2020. ALPP is going to be releasing Q1 earnings soon and all this talk of dilution seems to be scare tactics to me. Grab some ALPP and hold for the end of the year when things really go into overdrive. Fundamentals are all the same, debt being paid off, S-1 close to accepted.

Maybe some here can help me understand the double standard in the OTC realm. Earlier today TLSS released their 10-k detailing over 296 million share conversions in last 3 months. Triple ALPP O/S almost. Yet, investors are unphased. They also detailed a 44 million net loss, along with plans to reverse split up to a higher exchange. People loved this. What’s the difference? People hated the idea of a r/s for ALPP even though ours will be atleast 30 shares smaller. TLSS still has over 2 million $ in notes to convert (300 mil more shares) and have plans to raise the AS above 500 million. The double standard in the OTC is crazy, ALPP deserve a lot more recognition than it does. KENT prevented a massive dilution event like what happened with TLSS. He has grown revenue quarter over quarter for 4+ years now WHILE maintaining a lower net loss combined than TLSS in 1 year.

Somehow TLSS is loved for this? Net loss? Its because they are expanding. Dilution? Its fine they need money. Reverse split (50+-1) its fine they will uplist. People are overlooking the biggest gem here...and it boggles my mind.

I hope Kent goes through with a reverse split to uplist, there really is no excuse not too. Being on a higher exchange will finally give us the eval. we deserve. I am sick of the OTC. This is why ALPP is one of the last OTC’s I hold.

Been holding since I called out in my group at 1 cent last year, still up 20k and will keep holding for the forseable future. Like it or not, ALPP share price isn’t really an indicator of how the company is doing. Its a tough time for a lot of companies here and I can especially tell you some of our local ones are having just as much trouble getting stuff done and released as ALPP.

Holding Strong here. Looking forward to 2020 when we get bought.

Holding Strong here. Looking forward to 2020 when we get bought.

I think a lot of people are taking this LPC deal the wrong way. Tickers that use LPC in the past have needed fast cash to fix bad issues with debt and or paying off immediate financing of large events. These tickers tend to not have revenue and won't be generating revenue for a while. As seen by these tickers: Mar 20 UMRX open .42 Current stock price .458 - https://www.biospace.com/article/releases/unum-therapeutics-announces-common-stock-purchase-agreement-for-up-to-25-million-with-lincoln-park-capital/
Mar 27 ECOR open .4489 Current stock price .9554 https://www.massdevice.com/electrocore-selling-up-to-25m-in-stock-to-lincoln-park/
Mar 30 EQ open 2.94 current stock price 3.31 https://ir.equilliumbio.com/news-releases/news-release-details/equillium-announces-common-stock-purchase-agreement-15-million
Dec 27 MVIS .73 Current stock price .77 (was 1.82 3 days ago from run on news) https://picante.today/it/2019/12/28/125233/microvision-enters-into-16-million-common-stock-purchase-agreement-with-lincoln-park-capital/
Dec 18 2018 CFMS .4788 current stock price .9514 http://ir.conformis.com/news-releases/news-release-details/conformis-announces-common-stock-purchase-agreement
Nov 14 2019 AXRX open .63 current stock price .732 https://www.azurrx.com/investors/press-releases/2019/157-azurrx-biopharma-inc-announces-equity-purchase-agreement-for-up-to-15-million-with-lincoln-park-capital-fund-llc.html
Oct 25 2019 ALIM .63 Current stock price with split account 1.162 https://www.globenewswire.com/news-release/2019/10/25/1935679/0/en/Alimera-Sciences-Announces-Equity-Purchase-Agreement-for-up-to-20-Million-with-Lincoln-Park-Capital.html
LPC deals go right and best when the company does not need to utilize them. looking at recent 13-F filings, LPC is not even on the list for any of them. LPC deal is an option. not an obligation.

UTOPIA must cherry pick their stocks that LPC has done deals with. Here are some that have gone green since LPC 8-k was released:
Mar 20 UMRX open .42 Current stock price .458 - https://www.biospace.com/article/releases/unum-therapeutics-announces-common-stock-purchase-agreement-for-up-to-25-million-with-lincoln-park-capital/
Mar 27 ECOR open .4489 Current stock price .9554 https://www.massdevice.com/electrocore-selling-up-to-25m-in-stock-to-lincoln-park/
Mar 30 EQ open 2.94 current stock price 3.31 https://ir.equilliumbio.com/news-releases/news-release-details/equillium-announces-common-stock-purchase-agreement-15-million
Dec 27 MVIS .73 Current stock price .77 (was 1.82 3 days ago from run on news) https://picante.today/it/2019/12/28/125233/microvision-enters-into-16-million-common-stock-purchase-agreement-with-lincoln-park-capital/
Dec 18 2018 CFMS .4788 current stock price .9514 http://ir.conformis.com/news-releases/news-release-details/conformis-announces-common-stock-purchase-agreement
Nov 14 2019 AXRX open .63 current stock price .732 https://www.azurrx.com/investors/press-releases/2019/157-azurrx-biopharma-inc-announces-equity-purchase-agreement-for-up-to-15-million-with-lincoln-park-capital-fund-llc.html
Oct 25 2019 ALIM .63 Current stock price with split account 1.162 https://www.globenewswire.com/news-release/2019/10/25/1935679/0/en/Alimera-Sciences-Announces-Equity-Purchase-Agreement-for-up-to-20-Million-with-Lincoln-Park-Capital.html